Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways

Regardless of the presence or absence of specific diagnostic mutations, many cancer patients fail to respond to EGFR-targeted therapeutics, and a personalized approach is needed to identify putative (non)responders. We found previously that human peripheral blood and EGF can modulate the activities...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamashev, Dmitri, Shaban, Nina, Lebedev, Timofey, Prassolov, Vladimir, Suntsova, Maria, Raevskiy, Mikhail, Gaifullin, Nurshat, Sekacheva, Marina, Garazha, Andrew, Poddubskaya, Elena, Sorokin, Maksim, Buzdin, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453612/
https://www.ncbi.nlm.nih.gov/pubmed/37626832
http://dx.doi.org/10.3390/cells12162022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453612/
https://www.ncbi.nlm.nih.gov/pubmed/37626832
http://dx.doi.org/10.3390/cells12162022

Ejemplares similares